Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Market Cap

Anika Therapeutics has a market cap or net worth of $374.51 million as of April 25, 2024. Its market cap has decreased by -6.39% in one year.

• Market Cap: 374.51M
• Enterprise Value: 328.55M
• 1-Year Change: -6.39%
• Ranking: #3164
• Category: Small-Cap
• Stock Price: $25.58

Market Cap Chart

Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $374.51M, an increase of 631.47%. That is a compound annual growth rate of 8.14%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	379.90M	-1.22%
Apr 24, 2024	384.60M	0.42%
Apr 23, 2024	383.00M	-0.62%
Apr 22, 2024	385.40M	0.44%
Apr 19, 2024	383.70M	1.62%
Apr 18, 2024	377.60M	-1.02%
Apr 17, 2024	381.50M	0.71%
Apr 16, 2024	378.80M	0.77%
Apr 15, 2024	375.90M	1.27%
Apr 12, 2024	371.20M	-2.39%
Apr 11, 2024	380.30M	-0.96%
Apr 10, 2024	384.00M	-0.13%
Apr 9, 2024	384.50M	1.29%
Apr 8, 2024	379.60M	-0.24%
Apr 5, 2024	380.50M	-1.48%
Apr 4, 2024	386.20M	-1.05%
Apr 3, 2024	390.30M	1.75%
Apr 2, 2024	383.60M	0.52%
Apr 1, 2024	381.60M	1.17%
Mar 28, 2024	377.20M	-0.55%
Mar 27, 2024	379.30M	0.72%
Mar 26, 2024	376.60M	1.07%
Mar 25, 2024	372.60M	-1.45%
Mar 22, 2024	378.10M	0.29%
Mar 21, 2024	377.00M	-0.79%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Alto Neuroscience	379.87M
Lexicon Pharmaceuticals	379.20M
PepGen	378.96M
Adaptive Biotechnologies	378.69M
Replimune Group	377.53M
MultiPlan	374.30M
Surmodics	372.56M
Biomea Fusion	370.65M